The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 19, 2022

Filed:

Dec. 04, 2018
Applicant:

Shenzhen Targetrx, Inc., Guangdong, CN;

Inventors:

Yihan Wang, Guangdong, CN;

Jiuyang Zhao, Guangdong, CN;

Assignee:

Shenzhen TargetRx, Inc., Guangdong, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/675 (2006.01); C07F 9/02 (2006.01); A61P 31/14 (2006.01); A61P 31/18 (2006.01); C07F 9/6561 (2006.01); A61P 31/22 (2006.01);
U.S. Cl.
CPC ...
A61K 31/675 (2013.01); A61P 31/14 (2018.01); A61P 31/18 (2018.01); A61P 31/22 (2018.01); C07F 9/65616 (2013.01);
Abstract

The present invention relates to a compound of a novel antiviral nucleoside reverse transcriptase inhibitor, a pharmaceutical composition containing the compound, and preparation and application of the compound. Specifically, disclosed in the present invention are a fused pyrimidine compound as represented by formula (I) and a pharmaceutical composition comprising the compound, or a pharmaceutically acceptable salt, stereoisomer, solvate, hydrate, crystal form, prodrug or isotopic derivative of the compound. The compound of the present invention can be used for treatment and/or prevention of infectious diseases caused by viruses, such as human immunodeficiency virus (HIV), hepatitis B virus (HBV).


Find Patent Forward Citations

Loading…